Abstract
Ventolin (salbutamol) and Medihaler-Duo (isoprenaline/phenylephrine combination) standard pressurized inhalers were used to administer doses of two or six “puffs” to 16 patients with known reversible airways obstruction. The doses were administered in random order over two days. Both the Ventolin and Medihaler-Duo inhalers substantially increased FEV1, but in the doses used salbutamol was more effective than isoprenaline/phenylephrine (P < 0·01). There was no significant difference between two and six puffs of salbutamol, though there seemed to be an advantage of six puffs of isoprenaline/phenylephrine over two puffs (P < 0·05). Adrenaline (1/1,000) 0·5 ml and atropine 0·6 mg produced similar increases in FEV1 to those produced by salbutamol.
The Pao2 fell more than 5 mm Hg in three patients after salbutamol and in three after isoprenaline/phenylephrine. There was no significant fall in mean Pao2 in any of the treatment groups. It is concluded that the Ventolin inhalant, administered in the conventional dose of two puffs, is as effective a bronchodilator as subcutaneous adrenaline and atropine, is more effective than the Medihaler-Duo, and is without detectable side effects.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ALTOUNYAN R. E. VARIATION OF DRUG ACTION ON AIRWAY OBSTRUCTION IN MAN. Thorax. 1964 Sep;19:406–415. doi: 10.1136/thx.19.5.406. [DOI] [PMC free article] [PubMed] [Google Scholar]
- AVIADO D. M., Jr, SCHMIDT C. F. Effects of sympathomimetic drugs on pulmonary circulation: with special reference to a new pulmonary vasodilator. J Pharmacol Exp Ther. 1957 Aug;120(4):512–527. [PubMed] [Google Scholar]
- Attwood E. C., Brooks W., Leckie W. J. Anaesthesia suitable for prolonged bronchoscopic examination. Thorax. 1970 Sep;25(5):540–543. doi: 10.1136/thx.25.5.540. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bass B. H., Disney M. E., Morrison-Smith J. Effect of salbutamol on respiratory function in children with asthma. Lancet. 1969 Aug 23;2(7617):438–438. doi: 10.1016/s0140-6736(69)90151-2. [DOI] [PubMed] [Google Scholar]
- Brittain R. T., Farmer J. B., Jack D., Martin L. E., Simpson W. T. Alpha-[(t-Butylamino)methyl]-4-hydroxy-m-xylene-alpha 1,alpha 3-diol (AH.3365): a selective beta-adrenergic stimulant. Nature. 1968 Aug 24;219(5156):862–863. doi: 10.1038/219862a0. [DOI] [PubMed] [Google Scholar]
- COHEN A. A., HALE F. C. COMPARATIVE EFFECTS OF ISOPROTERENOL AEROSOLS ON AIRWAY RESISTANCE IN OBSTRUCTIVE PULMONARY DISEASES. Am J Med Sci. 1965 Mar;249:309–315. doi: 10.1097/00000441-196503000-00010. [DOI] [PubMed] [Google Scholar]
- Choo-Kang Y. F., Simpson W. T., Grant I. W. Controlled comparison of the bronchodilator effects of three beta-adrenergic stimulant drugs administered by inhalation to patients with asthma. Br Med J. 1969 May 3;2(5652):287–289. doi: 10.1136/bmj.2.5652.287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cohen B. M. 'Metered' aerosols of bronchodilator drugs in clinical trials. Influence of the method of administration. Thorax. 1971 May;26(3):316–318. doi: 10.1136/thx.26.3.316. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Crompton G. K. A comparison of responses to bronchodilator drugs in chronic bronchitis and chronic asthma. Thorax. 1968 Jan;23(1):46–55. doi: 10.1136/thx.23.1.46. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Freedman B. J., Meisner P., Hill G. B. A comparison of the actions of different bronchodilators in asthma. Thorax. 1968 Nov;23(6):590–597. doi: 10.1136/thx.23.6.590. [DOI] [PMC free article] [PubMed] [Google Scholar]
- GOLDFARB A. A., ROMANOFF A. Clinical evaluation of a new triple drug aerosol for asthma. Ann Allergy. 1962 May;20:307–314. [PubMed] [Google Scholar]
- HORVATH S. M., KNAPP D. W. Hemodynamic effects of neosynephrine. Am J Physiol. 1954 Sep;178(3):387–391. doi: 10.1152/ajplegacy.1954.178.3.387. [DOI] [PubMed] [Google Scholar]
- HUME K. M., GANDEVIA B. Forced expiratory volume before and after isoprenaline. Thorax. 1957 Sep;12(3):276–278. doi: 10.1136/thx.12.3.276. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HUME K. M., RHYS JONES E. The response to bronchodilators in intrinsic asthma. Q J Med. 1961 Apr;30:189–199. [PubMed] [Google Scholar]
- Harris L. H. Effects of isoprenaline plus phenylephrine by pressurized aerosol on blood gases, ventilation, and perfusion in chronic obstructive lung disease. Br Med J. 1970 Dec 5;4(5735):579–582. doi: 10.1136/bmj.4.5735.579. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kelman G. R., Palmer K. N., Cross M. R. Cardiovascular effects of AH.3365 (salbutamol). Nature. 1969 Mar 29;221(5187):1251–1251. doi: 10.1038/2211251a0. [DOI] [PubMed] [Google Scholar]
- Kennedy M. C., Simpson W. T. Human pharmacological and clinical studies on salbutamol: a specific beta-adrenergic bronchodilator. Br J Dis Chest. 1969 Jul;63(3):165–174. doi: 10.1016/s0007-0971(69)80014-8. [DOI] [PubMed] [Google Scholar]
- Legge J. S., Gaddie J., Palmer K. N. Comparison of two oral selective beta2-adrenergic stimulant drugs in bronchial asthma. Br Med J. 1971 Mar 20;1(5750):637–639. doi: 10.1136/bmj.1.5750.637. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Palmer K. N., Diament M. L. Effect of salbutamol on spirometry and blood-gas tensions in bronchial asthma. Br Med J. 1969 Jan 4;1(5635):31–32. doi: 10.1136/bmj.1.5635.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Palmer K. N., Legge J. S., Hamilton W. F., Diament M. L. Comparison of effect of salbutamol and isoprenaline on spirometry and blood-gas tensions in bronchial asthma. Br Med J. 1970 Apr 4;2(5700):23–24. doi: 10.1136/bmj.2.5700.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zamel N., Faraco E. Z., De Freitas F. M. Effect of norepinephrine and isoprenaline on the airway resistance of patients with chronic bronchial obstruction. Thorax. 1966 Jul;21(4):333–336. doi: 10.1136/thx.21.4.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
